PL2850100T3 - Rekombinowana bakteryjna komórka gospodarz do ekspresji białka - Google Patents

Rekombinowana bakteryjna komórka gospodarz do ekspresji białka

Info

Publication number
PL2850100T3
PL2850100T3 PL13723086T PL13723086T PL2850100T3 PL 2850100 T3 PL2850100 T3 PL 2850100T3 PL 13723086 T PL13723086 T PL 13723086T PL 13723086 T PL13723086 T PL 13723086T PL 2850100 T3 PL2850100 T3 PL 2850100T3
Authority
PL
Poland
Prior art keywords
host cell
protein expression
bacterial host
recombinant bacterial
recombinant
Prior art date
Application number
PL13723086T
Other languages
English (en)
Inventor
Philip Jonathan Bassett
David Paul Humphreys
Pareshkumar Manjibhai PATEL
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of PL2850100T3 publication Critical patent/PL2850100T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
PL13723086T 2012-05-14 2013-05-13 Rekombinowana bakteryjna komórka gospodarz do ekspresji białka PL2850100T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201208367A GB201208367D0 (en) 2012-05-14 2012-05-14 Biological product
PCT/EP2013/059803 WO2013171156A1 (en) 2012-05-14 2013-05-13 Recombinant bacterial host cell for protein expression
EP13723086.8A EP2850100B1 (en) 2012-05-14 2013-05-13 Recombinant bacterial host cell for protein expression

Publications (1)

Publication Number Publication Date
PL2850100T3 true PL2850100T3 (pl) 2019-04-30

Family

ID=46458730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13723086T PL2850100T3 (pl) 2012-05-14 2013-05-13 Rekombinowana bakteryjna komórka gospodarz do ekspresji białka

Country Status (30)

Country Link
US (2) US9951365B2 (pl)
EP (1) EP2850100B1 (pl)
JP (2) JP6420759B2 (pl)
KR (1) KR102036399B1 (pl)
CN (2) CN110591991A (pl)
AU (1) AU2013261915B2 (pl)
BR (1) BR112014027357A2 (pl)
CA (1) CA2872328C (pl)
CL (1) CL2014003112A1 (pl)
CO (1) CO7240426A2 (pl)
CY (1) CY1121192T1 (pl)
DK (1) DK2850100T3 (pl)
EA (1) EA201492100A1 (pl)
ES (1) ES2704425T3 (pl)
GB (1) GB201208367D0 (pl)
HR (1) HRP20190025T1 (pl)
HU (1) HUE040624T2 (pl)
IL (1) IL235041B (pl)
LT (1) LT2850100T (pl)
ME (1) ME03309B (pl)
MX (1) MX353066B (pl)
MY (1) MY166223A (pl)
PL (1) PL2850100T3 (pl)
PT (1) PT2850100T (pl)
RS (1) RS58219B1 (pl)
SG (1) SG11201406474RA (pl)
SI (1) SI2850100T1 (pl)
SM (1) SMT201900011T1 (pl)
TR (1) TR201900073T4 (pl)
WO (1) WO2013171156A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2993231T1 (sl) 2009-09-24 2018-10-30 Ucb Biopharma Sprl Bakterijski sev za izražanje rekombinantnega proteina, ki ima proteazno deficientno DEGP-zadrževalno šaperonsko aktivnost, ter onesposobljena gena TSP in PTR
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
WO2013007388A1 (en) 2011-07-13 2013-01-17 Ucb Pharma, S.A. Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
EP4467565A3 (en) 2016-12-21 2025-03-12 Amgen Inc. Anti-tnf alpha antibody formulations
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
WO2019213331A1 (en) 2018-05-01 2019-11-07 Ambrx, Inc. A method for optimizing antibody expression
AU2019375413A1 (en) * 2018-11-05 2021-05-27 Genentech, Inc. Methods of producing two chain proteins in prokaryotic host cells
AU2020243460A1 (en) 2019-03-18 2021-10-07 Bio-Rad Abd Serotec Gmbh Protection of SpyTag-containing periplasmic fusion proteins from protease Tsp and ompT degradation
KR20250018382A (ko) 2022-05-30 2025-02-05 한올바이오파마주식회사 안정성이 향상된 항-FcRn 항체 또는 이의 항원 결합 단편

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US6027888A (en) 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
CA2346797C (en) 1998-10-28 2008-09-23 Genentech, Inc. Process for recovering heterologous polypeptides from bacterial cells
ATE343790T1 (de) 1999-06-29 2006-11-15 Siga Technologies Inc Test für degp-protease inhibitoren
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
AU2001287040A1 (en) 2000-09-01 2002-03-13 Biogen, Inc. Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
CZ304484B6 (cs) 2000-12-14 2014-05-21 Genentech, Inc. Bakteriální hostitelské kmeny a způsob tvorby polypeptidu
EP1356052B1 (en) * 2000-12-14 2008-08-20 Genentech, Inc. Production of full antibodies in procaryotic cells
TWI327597B (en) 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
ATE382053T1 (de) 2001-08-27 2008-01-15 Genentech Inc System zur antikörperexpression und- synthese
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
DE60230918D1 (de) 2001-11-16 2009-03-05 Biogen Idec Inc Polycistronische expression von antikörpern in cho zellen
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
AU2003244817B2 (en) 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
GB0224082D0 (en) 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
US7608429B2 (en) 2002-10-31 2009-10-27 Genentech, Inc. Methods and compositions for increasing antibody production
PT1570267E (pt) 2002-12-03 2012-01-03 Ucb Pharma Sa Ensaio para a identificação de células produtoras de anticorpos
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
NZ544486A (en) 2003-06-13 2009-04-30 Biogen Idec Inc Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
NZ580688A (en) 2003-07-26 2012-03-30 Biogen Idec Inc Method of designing altered antibodies having improved antigen-binding affinity
WO2006078273A2 (en) * 2004-04-26 2006-07-27 The United States Of America As Represented By Teh Secretary Of Health And Human Services, Nih Methods and compositions for producing recombinant proteins
JP5102028B2 (ja) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗cd154抗体
AU2005282700A1 (en) 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
EP2125894B1 (en) 2007-03-22 2018-12-19 Biogen MA Inc. Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
CA2700714C (en) 2007-09-26 2018-09-11 Ucb Pharma S.A. Dual specificity antibody fusions
PT2334705T (pt) 2008-09-26 2017-03-22 Ucb Biopharma Sprl Produtos biológicos
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
SI2993231T1 (sl) 2009-09-24 2018-10-30 Ucb Biopharma Sprl Bakterijski sev za izražanje rekombinantnega proteina, ki ima proteazno deficientno DEGP-zadrževalno šaperonsko aktivnost, ter onesposobljena gena TSP in PTR
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
MX2012005168A (es) 2009-11-05 2012-06-08 Genentech Inc Metodos y composicion para secrecion de polipeptidos heterologos.
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000588D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) * 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
WO2013007388A1 (en) * 2011-07-13 2013-01-17 Ucb Pharma, S.A. Bacterial host strain expressing recombinant dsbc
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Also Published As

Publication number Publication date
IL235041B (en) 2019-10-31
KR102036399B1 (ko) 2019-10-24
MX2014012623A (es) 2015-01-15
RS58219B1 (sr) 2019-03-29
SI2850100T1 (sl) 2019-02-28
AU2013261915B2 (en) 2017-12-14
US9951365B2 (en) 2018-04-24
JP2015516166A (ja) 2015-06-11
CA2872328A1 (en) 2013-11-21
CN104487454A (zh) 2015-04-01
MX353066B (es) 2017-12-19
AU2013261915A1 (en) 2014-12-18
MY166223A (en) 2018-06-22
PT2850100T (pt) 2019-01-21
IL235041A0 (en) 2014-12-31
CN110591991A (zh) 2019-12-20
DK2850100T3 (en) 2019-02-04
SG11201406474RA (en) 2014-11-27
LT2850100T (lt) 2019-01-25
CL2014003112A1 (es) 2015-06-19
WO2013171156A1 (en) 2013-11-21
CA2872328C (en) 2020-10-13
CY1121192T1 (el) 2020-05-29
US20180258457A1 (en) 2018-09-13
ES2704425T3 (es) 2019-03-18
CO7240426A2 (es) 2015-04-17
GB201208367D0 (en) 2012-06-27
JP2018198597A (ja) 2018-12-20
EA201492100A1 (ru) 2015-02-27
US11261470B2 (en) 2022-03-01
EP2850100A1 (en) 2015-03-25
US20150111249A1 (en) 2015-04-23
HUE040624T2 (hu) 2019-03-28
HRP20190025T1 (hr) 2019-02-22
SMT201900011T1 (it) 2019-02-28
KR20150014936A (ko) 2015-02-09
ME03309B (me) 2019-10-20
EP2850100B1 (en) 2018-10-10
TR201900073T4 (tr) 2019-01-21
JP6420759B2 (ja) 2018-11-07
BR112014027357A2 (pt) 2017-08-08

Similar Documents

Publication Publication Date Title
IL235041B (en) Recombinant bacterial host cell for protein expression
SI2822577T1 (sl) Rekombinantni proteini faktorja VIII
ZA201300147B (en) Recombinant host cells comprising phosphoketolases
BR112014024675A8 (pt) célula hospedeira recombinante, cultura celular
IL238176A0 (en) Proteins occupy the space of a recombinant cell
IL239285A0 (en) Yogurts with high protein
IL237740A0 (en) Recombinant organisms
PL2858489T3 (pl) Rekombinowane elementy dna do ekspresji rekombinowanych białek w komórce gospodarzu
PT2964775T (pt) Promotores de leveduras para a expressão proteica
PL2714888T3 (pl) Rekombinowane drożdże
ZA201406434B (en) Improved harvest operations for recombinant proteins
PL2714902T3 (pl) Wektory ekspresyjne do polepszonej sekrecji białka
KR20180085063A (ko) 신규 단백질 소재
GB201107468D0 (en) Protein expression systems
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
EP2851083B8 (en) Radiation-sterilization-resistant protein composition
GB201213672D0 (en) Protein
GB201203587D0 (en) Modified bacterial cell
SG11201504096RA (en) Recombinant protein
GB201103169D0 (en) Protein expression
HUP1200080A2 (en) Biotin labeled protein expression system
GB201215901D0 (en) Protein modification
HUP1100282A2 (en) Protein factor
AU2011904284A0 (en) Novel protein
GB201210286D0 (en) Recombinant polypeptide